Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
Author:
Affiliation:
1. The Townsville Hospital; Department of Vascular Surgery; Townsville Queensland Australia 4814
2. James Cook University Hospital; Department of Vascular Surgery; Marton Road Middlesbrough UK TS4 3BW
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003074.pub3/fullpdf
Reference76 articles.
1. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group;Charbonnier;Thrombosis and Haemostasis,1998
2. Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg;Holmström;Thrombosis Research,1992
3. Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT);Holmström;Journal of Internal Medicine Supplement,1990
4. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease;Merli;Annals of Internal Medicine,2001
5. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin;Partsch;Journal of Vascular Surgery,1996
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline;Neurological Research and Practice;2024-04-19
2. The S2k guideline on the diagnosis and treatment of venous thrombosis and pulmonary embolism;Vasa;2023-10-01
3. Prevalence of perioperative asymptomatic venous thromboses of the lower extremity in 30 consecutive patients undergoing transsphenoidal surgery for Cushing’s disease;Scientific Reports;2023-02-24
4. Management of thromboembolic disorders during pregnancy in resource-constrained settings: An Indian perspective;Indian Journal of Medical Research;2023
5. Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses;European Journal of Clinical Pharmacology;2022-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3